Assessment of antimicrobial stewardship programmes and antibiotic use among children admitted to two hospitals in Sierra Leone: a cross-sectional study.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
22 Jul 2024
Historique:
received: 02 03 2024
accepted: 14 06 2024
medline: 23 7 2024
pubmed: 23 7 2024
entrez: 22 7 2024
Statut: epublish

Résumé

Antimicrobial resistance (AMR) is a global public health concern and irrational use of antibiotics in hospitals is a key driver of AMR. Even though it is not preventable, antimicrobial stewardship (AMS) programmes will reduce or slow it down. Research evidence from Sierra Leone has demonstrated the high use of antibiotics in hospitals, but no study has assessed hospital AMS programmes and antibiotic use specifically among children. We conducted the first-ever study to assess the AMS programmes and antibiotics use in two tertiary hospitals in Sierra Leone. This was a hospital-based cross-sectional survey using the World Health Organization (WHO) point prevalence survey (PPS) methodology. Data was collected from the medical records of eligible patients at the Ola During Children's Hospital (ODCH) and Makeni Regional Hospital (MRH) using the WHO PPS hospital questionnaire; and required data collection forms. The prescribed antibiotics were classified according to the WHO Access, Watch, and Reserve (AWaRe) classification. Ethics approval was obtained from the Sierra Leone Ethics and Scientific Review Committee. Statistical analysis was conducted using the SPSS version 22. Both ODCH and MRH did not have the required AMS infrastructure; policy and practice; and monitoring and feedback mechanisms to ensure rational antibiotic prescribing. Of the 150 patients included in the survey, 116 (77.3%) were admitted at ODCH and 34 (22.7%) to MRH, 77 (51.3%) were males and 73 (48.7%) were females. The mean age was 2 years (SD=3.5). The overall prevalence of antibiotic use was 84.7% (95% CI: 77.9% - 90.0%) and 77 (83.8%) of the children aged less than one year received an antibiotic. The proportion of males that received antibiotics was higher than that of females. Most (58, 47.2 %) of the patients received at least two antibiotics. The top five antibiotics prescribed were gentamycin (100, 27.4%), ceftriaxone (76, 20.3%), ampicillin (71, 19.5%), metronidazole (44, 12.1%), and cefotaxime (31, 8.5%). Community-acquired infections were the primary diagnoses for antibiotic prescription. The non-existence of AMS programmes might have contributed to the high use of antibiotics at ODCH and MRH. This has the potential to increase antibiotic selection pressure and in turn the AMR burden in the country. There is need to establish hospital AMS teams and train health workers on the rational use of antibiotics.

Identifiants

pubmed: 39039593
doi: 10.1186/s13756-024-01425-1
pii: 10.1186/s13756-024-01425-1
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

80

Informations de copyright

© 2024. The Author(s).

Références

Kamara IF, et al. Infection Prevention and Control in Three Tertiary Healthcare Facilities in Freetown, Sierra Leone during the COVID-19 Pandemic: More Needs to Be Done! Int J Environ Res Public Health. 2022;19(9):5275.
Kariuki S, et al. Antimicrobial resistance rates and surveillance in sub-saharan africa: where are we now? Infect Drug Resist. 2022;15:3589–609.
doi: 10.2147/IDR.S342753 pubmed: 35837538 pmcid: 9273632
Kamara IF, et al. Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020-2021: Practice Does Not Follow Policy. Int J Environ Res Public Health. 2022;19(7):4005.
World Health Organization. Antimicrobial resistance. 2021 7 March 2021]; Available from: https://www.who.int/health-topics/antimicrobial-resistance .
Murray CJ, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–55.
doi: 10.1016/S0140-6736(21)02724-0
INSTITUTE FOR HEALTH METRICS AND EVALUATION. The burden of antimicrobial resistance (AMR) in Sierra Leone. 2023; Available from: https://www.healthdata.org/sites/default/files/2023-09/Sierra_Leone.pdf .
Gautron JMC, et al. Using intersectionality to study gender and antimicrobial resistance in low- and middle-income countries. Health Policy Plann. 2023;38(9):1017–32.
doi: 10.1093/heapol/czad054
Jones N, et al. Gender and antimicrobial resistance: what can we learn from applying a gendered lens to data analysis using a participatory arts case study? Front Global Women’s Health. 2022;3:745862.
doi: 10.3389/fgwh.2022.745862
Tersigni C, et al. Antimicrobial stewardship in children: more shadows than lights? Expert Rev Anti Infect Ther. 2019;17(11):871–6.
doi: 10.1080/14787210.2019.1686355 pubmed: 31661998
Romandini A, et al. Antibiotic Resistance in Pediatric Infections: Global Emerging Threats, Predicting the Near Future. Antibiotics (Basel). 2021;10(4):393.
Wattal C, Goel N. Pediatric blood cultures and antibiotic resistance: an overview. Indian J Pediatr. 2020;87(2):125–31.
doi: 10.1007/s12098-019-03123-y pubmed: 31863394
Alvarez-Uria G, Gandra S, Laxminarayan R. Poverty and prevalence of antimicrobial resistance in invasive isolates. Int J Infect Dis. 2016;52:59–61.
doi: 10.1016/j.ijid.2016.09.026 pubmed: 27717858
Alsan M, et al. Poverty and community-acquired antimicrobial resistance with extended-spectrum β-lactamase–producing organisms, Hyderabad, India. Emerg Infect Dis. 2018;24(8):1490.
doi: 10.3201/eid2408.171030 pubmed: 30014842 pmcid: 6056104
Duong QA, et al. Antibiotic exposure and adverse long-term health outcomes in children: a systematic review and meta-analysis. J Infect. 2022;85(3):213–300.
doi: 10.1016/j.jinf.2022.01.005 pubmed: 35021114
Channon-Wells S, et al. National point-prevalence survey of healthcare-associated infections and antimicrobial use: UK-PAS/UKHSA joint call to action for all paediatric services. J Antimicrob Chemother. 2023;78(10):2392–4.
doi: 10.1093/jac/dkad265 pubmed: 37611224 pmcid: 10805576
Iroh Tam PY, et al. Antimicrobial resistance among children in Africa: need for paediatric clinical trials. Expert Rev Anti Infect Ther. 2020;18(10):955–6.
doi: 10.1080/14787210.2020.1782741 pubmed: 32538200
Katyali D, et al. Antibiotic use at a tertiary hospital in Tanzania: findings from a point prevalence survey. Antimicrob Resist Infect Control. 2023;12(1):112.
doi: 10.1186/s13756-023-01317-w pubmed: 37817204 pmcid: 10566109
Mthombeni TC, et al. Antibiotic prescribing to inpatients in Limpopo, South Africa: a multicentre point-prevalence survey. Antimicrob Resist Infect Control. 2023;12(1):103.
doi: 10.1186/s13756-023-01306-z pubmed: 37717012 pmcid: 10505321
Klein EY, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci. 2018;115(15):E3463–70.
doi: 10.1073/pnas.1717295115 pubmed: 29581252 pmcid: 5899442
Davey P, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013(4):CD003543.
Schuts EC, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847–56.
doi: 10.1016/S1473-3099(16)00065-7 pubmed: 26947617
Pollack LA, et al. Antibiotic stewardship programs in US acute care hospitals: findings from the 2014 National Healthcare Safety Network Annual Hospital Survey. Rev Infect Dis. 2016;63(4):443–9.
doi: 10.1093/cid/ciw323
Van Dijck C, Vlieghe E, Cox JA. Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review. Bull World Health Organ. 2018;96(4):266.
doi: 10.2471/BLT.17.203448 pubmed: 29695883 pmcid: 5872012
Cox JA, et al. Antibiotic stewardship in low-and middle-income countries: the same but different? Clin Microbiol Infect. 2017;23(11):812–8.
doi: 10.1016/j.cmi.2017.07.010 pubmed: 28712667
Kamara IF, et al. Antibiotic use among hospitalised patients in Sierra Leone: a national point prevalence survey using the WHO survey methodology. BMJ Open. 2023;13(12):e078367.
doi: 10.1136/bmjopen-2023-078367 pubmed: 38159961 pmcid: 10759135
Moon TD, et al. Antibiotic prescribing practices for acute respiratory illness in children less than 24 months of age in Kenema, Sierra Leone: is it time to move beyond algorithm driven decision making? BMC Infect Dis. 2023;23(1):626.
doi: 10.1186/s12879-023-08606-0 pubmed: 37749485 pmcid: 10519098
Lakoh, S., et al. Establishing an Antimicrobial Stewardship Program in Sierra Leone: A Report of the Experience of a Low-Income Country in West Africa. Antibiotics, 2023. 12, https://doi.org/10.3390/antibiotics12030424 .
WHO. WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals. 2019. Cited 2021 23/02/2021; Available from: https://www.who.int/publications/i/item/WHO-EMP-IAU-2018.01 .
World Bank. Population, total - Sierra Leone. 2024; Available from: https://data.worldbank.org/indicator/SP.POP.TOTL?locations=SL .
Zembe J, et al. Population health trends analysis and burden of disease profile observed in Sierra Leone from 1990 to 2017. BMC Public Health. 2022;22(1):1801.
doi: 10.1186/s12889-022-14104-w pubmed: 36138457 pmcid: 9494828
IGME. UN Inter-agency Group for Child Mortality Estimation. 2023; Available from: https://childmortality.org/all-cause-mortality/data?refArea=SLE .
Ministry of Health (MOH). Sierra Leone Essential Health Service Package. 2022; Available from: https://mohs.gov.sl/policy-documents/ .
Kamara RZ, et al. Improvement in Infection Prevention and Control Compliance at the Three Tertiary Hospitals of Sierra Leone following an Operational Research Study. Trop Med Infect Dis. 2023;8(7):378.
Lakoh S, et al. Antibiotic use and consumption among medical patients of two hospitals in Sierra Leone: a descriptive report. BMC Infect Dis. 2023;23(1):737.
doi: 10.1186/s12879-023-08517-0 pubmed: 37891476 pmcid: 10612171
CHAMPS. Building and Sharing Knowledge. 2024; Available from: https://champshealth.org/ .
World Health Organization. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. 2022; Available from: https://www.who.int/publications/i/item/9789240062382 .
Anugulruengkitt S, et al. Point prevalence survey of antibiotic use among hospitalized patients across 41 hospitals in Thailand. JAC Antimicrob Resist. 2023;5(1):dlac140.
doi: 10.1093/jacamr/dlac140
Chilot D, et al. Pooled prevalence and risk factors of malaria among children aged 6–59 months in 13 sub-Saharan African countries: A multilevel analysis using recent malaria indicator surveys. PLoS One. 2023;18(5):e0285265.
doi: 10.1371/journal.pone.0285265 pubmed: 37256889 pmcid: 10231787
Akpan MR, et al. Implementation of antimicrobial stewardship programmes in African countries: a systematic literature review. J Glob Antimicrob Resist. 2020;22:317–24.
doi: 10.1016/j.jgar.2020.03.009 pubmed: 32247077
Lakoh S, et al. Antibiotic use and consumption in Freetown, Sierra Leone: a baseline report of prescription stewardship in outpatient clinics of three tertiary hospitals. IJID Reg. 2023;7:43–51.
doi: 10.1016/j.ijregi.2023.02.004 pubmed: 37038468 pmcid: 10082370
Wang CN, et al. Antibiotic use among hospitalized children and neonates in China: results from quarterly point prevalence surveys in 2019. Front Pharmacol. 2021;12:601561.
doi: 10.3389/fphar.2021.601561 pubmed: 33854430 pmcid: 8039455
Meesters K, Buonsenso D. Antimicrobial stewardship in pediatric emergency medicine: a narrative exploration of antibiotic overprescribing, stewardship interventions, and performance metrics. Children. 2024;11(3):276.
doi: 10.3390/children11030276 pubmed: 38539311 pmcid: 10968970
Rousham EK, et al. Gender and urban-rural influences on antibiotic purchasing and prescription use in retail drug shops: a one health study. BMC Public Health. 2023;23(1):229.
doi: 10.1186/s12889-023-15155-3 pubmed: 36732727 pmcid: 9896778
Schröder W, et al. Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis. J Antimicrob Chemother. 2016;71(7):1800–6.
doi: 10.1093/jac/dkw054 pubmed: 27040304
Kilipamwambu, A., et al., WHO/INRUD core prescribing indicators and antibiotic utilization patterns among primary health care facilities in Ilala district, Tanzania. JAC Antimicrob Resist, 2021. 3(2): p. dlab049.
Mudenda S, et al. Hospital prescribing patterns of antibiotics in Zambia using the WHO prescribing indicators post-COVID-19 pandemic: findings and implications. JAC Antimicrob Resist. 2024;6(1):dlab049.
World Health Organization. WHO Model List of Essential Medicines for Children - 8th list, 2021. 2021; Available from: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.03 .
Alabi AS, et al. Implementation of an antimicrobial stewardship programme in three regional hospitals in the south-east of Liberia: lessons learned. JAC-Antimicrob Resist. 2022;4(3):dlac069.
Labi AK, et al. Antibiotic consumption trends in Ghana: analysis of six-years pharmacy issue data from a secondary healthcare facility. JAC Antimicrob Resist. 2023;5(2):dlad025.
doi: 10.1093/jacamr/dlad025 pubmed: 36960316
Sneddon J, et al. Accreditation of antimicrobial stewardship programmes: addressing a global need to tackle antimicrobial resistance. JAC-Antimicrob Resist. 2024;6(1):dlae007.
Collaborators, W.A.R.N.I.N.G.W. Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action. World J Emerg Surg. 2023;18(1):50.
doi: 10.1186/s13017-023-00518-3

Auteurs

Ibrahim Franklyn Kamara (IF)

Reproductive Maternal Newborn Child and Adolescent Unit, Universal Health Coverage, Life Course Cluster, World Health Organization Country Office, 21 A-B Riverside Off Kingharman Road, Freetown, Sierra Leone. ibrahimfranklynkamara@outlook.com.
Reproductive maternal newborn child and adolescent health unit, Universal Health Coverage, Life Course Cluster, WHO Country Office in Sierra Leone, Freetown, Sierra Leone. ibrahimfranklynkamara@outlook.com.

Bobson Derrick Fofanah (BD)

Reproductive Maternal Newborn Child and Adolescent Unit, Universal Health Coverage, Life Course Cluster, World Health Organization Country Office, 21 A-B Riverside Off Kingharman Road, Freetown, Sierra Leone.

Innocent Nuwagira (I)

Reproductive Maternal Newborn Child and Adolescent Unit, Universal Health Coverage, Life Course Cluster, World Health Organization Country Office, 21 A-B Riverside Off Kingharman Road, Freetown, Sierra Leone.

Kadijatu Nabie Kamara (KN)

Ministry of Health, Fourth Floor, Youyi Building, Brookfields, Freetown, Sierra Leone.

Sia Morenike Tengbe (SM)

Ministry of Health, Fourth Floor, Youyi Building, Brookfields, Freetown, Sierra Leone.

Onome Abiri (O)

Pharmacy Board Sierra Leone, New England Ville, Freetown, Sierra Leone.
College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Rugiatu Z Kamara (RZ)

United States Centers for Disease Control and Prevention Country Office, Emergency Operation Centre, Wilkinson Road, Freetown, Sierra Leone.

Sulaiman Lakoh (S)

Ministry of Health, Fourth Floor, Youyi Building, Brookfields, Freetown, Sierra Leone.
College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Lynda Farma (L)

Ministry of Health, Fourth Floor, Youyi Building, Brookfields, Freetown, Sierra Leone.

Abibatu Kollia Kamara (AK)

Reproductive Maternal Newborn Child and Adolescent Unit, Universal Health Coverage, Life Course Cluster, World Health Organization Country Office, 21 A-B Riverside Off Kingharman Road, Freetown, Sierra Leone.

Binyam Hailu (B)

Reproductive Maternal Newborn Child and Adolescent Unit, Universal Health Coverage, Life Course Cluster, World Health Organization Country Office, 21 A-B Riverside Off Kingharman Road, Freetown, Sierra Leone.

Djossaya Dove (D)

Department of Demographic and Social Statistics, National Institute of Statistics, Yaoundé, Cameroon.

James Sylvester Squire (JS)

Ministry of Health, Fourth Floor, Youyi Building, Brookfields, Freetown, Sierra Leone.

Selassi A D'Almeida (SA)

Reproductive Maternal Newborn Child and Adolescent Unit, Universal Health Coverage, Life Course Cluster, World Health Organization Country Office, 21 A-B Riverside Off Kingharman Road, Freetown, Sierra Leone.

Bockarie Sheriff (B)

Reproductive Maternal Newborn Child and Adolescent Unit, Universal Health Coverage, Life Course Cluster, World Health Organization Country Office, 21 A-B Riverside Off Kingharman Road, Freetown, Sierra Leone.

Ayeshatu Mustapha (A)

Ministry of Health, Fourth Floor, Youyi Building, Brookfields, Freetown, Sierra Leone.

Najima Bawa (N)

Momentum Country and Global Leadership, Sir Samuel Lewis Road, Freetown, Sierra Leone.

Hailemariam Lagesse (H)

United Nation Children's Fund, Jomo Kenyatta Road, New England Ville, Freetown, Sierra Leone.

Aminata Tigiedankay Koroma (AT)

Ministry of Health, Fourth Floor, Youyi Building, Brookfields, Freetown, Sierra Leone.

Joseph Sam Kanu (JS)

Ministry of Health, Fourth Floor, Youyi Building, Brookfields, Freetown, Sierra Leone.
College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH